SCIENTURE HOLDINGS, INC. Proceeds from Notes Payable
SCIENTURE HOLDINGS, INC. (SCNX) reported Proceeds from Notes Payable of $10.59 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. proceeds from notes payable for the quarter ending 2018-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. proceeds from notes payable for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. proceeds from notes payable for the quarter ending 2016-12-31 was $59.16K.
- SCIENTURE HOLDINGS, INC. proceeds from notes payable for the quarter ending 2016-09-30 was $150.00K.
- SCIENTURE HOLDINGS, INC. proceeds from notes payable for fiscal 2016 was $209.16K, a 2.03% increase from fiscal 2015.
- SCIENTURE HOLDINGS, INC. proceeds from notes payable for fiscal 2015 was $205.00K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.59M 10-Q · filed 2026-08-13 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $0.00 10-Q · filed 2018-10-26 | ||
| 2018-06-30 | $0.00 10-Q · filed 2018-07-27 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $180.00K 10-Q · filed 2018-10-26 | ||
| 2017-06-30 | $180.00K 10-Q · filed 2018-07-27 | |||
| 2016-12-31 | $59.16K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $209.16K derived: sum of 2 quarters · filed 2017-03-30 | $209.16K 10-K · filed 2017-03-30 | |
| 2016-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $150.00K 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-05 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $0.00 derived: sum of 2 quarters · filed 2017-03-30 | $205.00K 10-K · filed 2017-03-30 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $205.00K 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $205.00K 10-Q · filed 2016-08-05 | |||
| 2014-09-30 | $10.00K 10-Q · filed 2015-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |